...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity.
【24h】

Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity.

机译:鉴定具有高激动剂敏感性的alpha4beta3delta GABAA受体的delta亚基(S238-V264)中的结构域。

获取原文
获取原文并翻译 | 示例

摘要

We have expressed the alpha4beta3delta and alpha4beta3gamma2L subtypes of the rat GABAA receptor in Xenopus oocytes and have investigated their agonist activation properties. GABA was a more potent agonist of the alpha4beta3delta receptor (EC50 approximately 1.4 micromol/L) than of the alpha4beta3gamma2L subtype (EC50 approximately 27.6 micromol/L). Other GABAA receptor agonists (muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol, imidazole-4-amino acid) displayed similar subtype selectivity. The structural determinants underlying these differences have been investigated by co-expressing chimeric delta/gamma2L subunits with alpha4 and beta3 subunits. A stretch of amino acids in the delta subunit, S238-V264, is shown to play an important role in determining both agonist potency and the efficacies of full or partial agonists. This segment includes transmembrane domain 1 and the short intracellular loop that leads to the second transmembrane domain. The effects of the competitive antagonists, bicuculline and SR95531, and the channel blocker, picrotoxin, were not significantly affected by the incorporation of chimeric subunits. As the delta and gamma2L subunits have not been previously implicated directly in agonist binding, we suggest that the effects are likely to arise from changes in the transduction mechanisms that link agonist binding to channel activation.
机译:我们已经在非洲爪蟾卵母细胞中表达了大鼠GABAA受体的alpha4beta3delta和alpha4beta3gamma2L亚型,并研究了其激动剂激活特性。与α4beta3gamma2L亚型(EC50约27.6 micromol / L)相比,GABA是α4beta3delta受体(EC50约1.4 micromol / L)更有效的激动剂。其他GABAA受体激动剂(麝香酚,4,5,6,7-四氢异恶唑并[5,4-c]吡啶-3-醇,咪唑-4-氨基酸)表现出相似的亚型选择性。通过共表达嵌合的delta / gamma2L亚基与alpha4和beta3亚基,已经研究了构成这些差异的结构决定因素。已显示出δ亚基S238-V264中的一段氨基酸在确定激动剂效力和全部或部分激动剂的效力中起重要作用。该区段包括跨膜结构域1和导致第二跨膜结构域的短细胞内环。嵌合亚基的掺入并没有显着影响竞争性拮抗剂bicuculline和SR95531以及通道阻滞剂微毒素的作用。由于以前没有直接将δ和γ2L亚基牵涉到激动剂结合中,因此我们认为这种作用很可能是由于将激动剂结合至通道活化的转导机制发生了变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号